2m 2m 2m 2m 2m 2m 2m
ROYAL PHARM -A (RPRX)
NASDAQ
$55.08+$1.51 (+2.82%)
Price as of Jun 23, 2026 6:03 PM EDT- $23.7BMarket Cap
- 54.58%1-Year Change
- BiotechnologyIndustry
ROYAL PHARM -A (RPRX)
$55.08+$1.51 (+2.82%)
RPRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $53.57 | ||
Change | +$0.61 (+1.15%) | ||
Open | $53.27 | ||
High | $53.71 | ||
Low | $52.89 | ||
Previous Close | $52.96 | ||
Volume | 4,091,976 | ||
30-Day Average Volume | 4,554,511 | ||
1-Week Change | -1.29% | ||
1-Month Change | -1.71% | ||
1-Year Change | 54.58% | ||
3-Year Change | 87.01% | ||
5-Year Change | 38.31% | ||
Fundamentals | |||
Shares Outstanding | 443.2M | ||
Total Assets | $19.8B | ||
Market Cap | $23.7B | ||
Enterprise Value | $32.1B | ||
Period: QTR TTM FY | |||
Revenue | $595.0M | ||
Net Income | $294.7M | ||
Free Cash Flow | $718.2M | ||
EBIT | $294.7M | ||
EBITDA | $295.9M | ||
Net Working Capital | $890.1M | ||
EPS | $0.67 | ||
Enterprise Value/EBITDA | 109 | ||
Enterprise Value/Revenue | 54 | ||
P/B | 2 | ||
P/E | 80 | ||
PEG | 1 | ||
Price/Free Cash Flow | 33 | ||
Price/Operating Cash Flow | 33 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 1.75% | ||
Trailing Annual Dividend Yield | 1.70% | ||
Ex-Dividend Date | 05/15/2026 | ||
Last Split Factor | 1 : 4 | ||
Last Split Date | 10/15/2010 | ||
Earnings & Revenue
Annual Dividend Yield